SEELOS THERAPEUTICS, INC. EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • June 18th, 2019 • Seelos Therapeutics, Inc. • Pharmaceutical preparations • New York
As further set forth in this agreement (this "Agreement"), Seelos Therapeutics, Inc., a company organized under the laws of Nevada (the "Company"), proposes to issue and sell from time to time through Piper Jaffray & Co. (the "Agent"), as sales agent, shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), having an aggregate offering price of up to $50,000,000 (such shares of Common Stock to be sold pursuant to this Agreement, the "Shares") on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.
